{"id":21022,"date":"2026-06-15T20:00:00","date_gmt":"2026-06-15T18:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=3c871549ca439e2df39116c8c4f0d717"},"modified":"2026-06-15T20:00:00","modified_gmt":"2026-06-15T18:00:00","slug":"isg-to-study-ai-service-providers-in-life-sciences","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=21022","title":{"rendered":"ISG to Study AI Service Providers in Life Sciences"},"content":{"rendered":"

\nUpcoming ISG Provider Lens\u00ae<\/sup> report will evaluate providers helping life sciences enterprises adopt AI for drug discovery, clinical development and commercial operations<\/b><\/p>

STAMFORD, Conn.--(BUSINESS WIRE)--$III<\/a> #AI<\/a>--Information Services Group (ISG<\/a>) (Nasdaq: III<\/a>), a global AI-centered technology research and advisory firm, has launched a research study examining providers that help enterprises improve research productivity, optimize development pipelines and enhance patient outcomes through AI.<\/p><\/a><\/a>

\nThe study results will be published in a comprehensive ISG Provider Lens\u00ae<\/sup> report, called AI Services in Life Sciences 2026 \u2014 Strategic Capabilities, scheduled to be released in November 2026. The report will cover companies offering services related to AI strategy and transformation, along with AI platform engineering, deployment and operationalization across the life sciences industry.<\/p>

\nEnterprise buyers will be able to use the report\u2019s insights to evaluate their current vendor relationships, identify potential new engagements and compare available offerings. ISG advisors will use the research to guide clients through increasingly complex transformation and platform investment decisions.<\/p>

\nLife sciences organizations are deploying AI in production as advances in generative AI, agentic AI and multimodal models enable more sophisticated scientific reasoning and knowledge discovery. Enterprises are increasingly using AI to integrate data from scientific literature, clinical records, imaging and laboratory systems for faster, more informed decision-making. As they expand AI initiatives, life sciences organizations are addressing growing demands for governance, explainability, regulatory compliance and cybersecurity.<\/p>

\n\u201cLife sciences enterprises are increasingly focused on translating AI investments into measurable scientific and business outcomes,\u201d said Iain Fisher, director, ISG. \u201cTo achieve sustainable value from responsibly deployed AI, they are turning to service providers to overcome numerous challenges, including workforce readiness and data quality and interoperability.\u201d<\/p>

\nISG has distributed surveys to more than 60 AI service providers in life sciences. Working in collaboration with ISG\u2019s global advisors, the research team will produce two quadrants representing the AI services that typical life sciences enterprises are seeking, based on ISG\u2019s experience working with its clients. The two quadrants are:<\/p>